Address
Other Office
3130 Highland Avenue
Suite 3205
Cincinnati, OH 45219
United States
Phone
Website
VCID: 30306
Profile
Corporate information
Official name
Charter Life Sciences Limited Partnership
Registration country
Official name
Charter Life Sciences Limited Partnership
Registration country
Investment activity status
Active investor
Company type
Venture capital fund with a focus on clinical stage life sciencesFund terms
Fund manager
Fund type
Funding
Funding rounds
Investments
Selected investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
Xlumena Inc Xlumena is a medical device company. |
United States | 1 Apr 2011 | Series B |
||
Great Lakes Pharmaceuticals Inc Developer of an anti-infective lock solution to address in-dwelling venous catheter mediated infection. |
United States | 1 Aug 2010 | Series B |
||
APT Pharmaceuticals Inc A pharmaceutical company focused on repurposing well-characterized drugs for under-served populations. |
United States | 1 Sep 2008 | Series A Initial investment. Round participant. Active |
||
Mirabilis Medica Inc Developer of non-invasive ultrasound technology for the treatment of uterine fibroids |
United States | N/A |
|||
Barrx Medical Inc Minimally invasive placed single use disposable medical device for the treatment of Barrett’s esophagus. |
United States | N/A Active |
|||
Intarcia Therapeutics Inc A biopharmaceutical company applying a targeted approach to the acquisition, development and commercialization of novel therapeutic products for the t |
United States | N/A |
|||
Revascular Therapeutics Inc |
United States | N/A |
|||
CoMentis Inc |
United States | N/A |
|||
KFx Medical Corp |
United States | N/A |
|||
EnteroMedics Inc Develops therapeutic devices for the treatment of obesity. Its VSM technology uses electrical signals, delivered by an implantable electrode array, to |
United States | N/A |
|||
Asthmatx Inc |
United States | Series D |
|||
Kereos Inc Kereos, Inc. develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease. |
United States | N/A |